We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Outlines Plans to Improve Drug Risk Assessment
FDA Outlines Plans to Improve Drug Risk Assessment
January 20, 2006
The FDA is undertaking changes to its premarket and postapproval risk-assessment programs in an effort to minimize the injuries patients suffer from prescription drugs, according to federal officials.